Decreased Leukocyte Accumulation and Delayed Bordetella pertussis Clearance in IL-6−/− Mice

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Immunology

• Publication date

  2011-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1000594PMID 21398615PMCID PMC3618952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammasome Activation by Adenylate Cyclase Toxin Directs Th17 Responses and Protection against Bordetella pertussis

  2010cited by this paper
• Interleukin-1 Receptor Signaling Is Required To Overcome the Effects of Pertussis Toxin and for Efficient Infection- or Vaccination-Induced Immunity against Bordetella pertussis

  2010cited by this paper
• Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo

  2009cited by this paper
• Pertussis Toxin Stimulates IL-17 Production in Response to Bordetella pertussis Infection in Mice

  2009cited by this paper
• Gamma Interferon and Interleukin-1 Receptor 1 Regulate Neutrophil Recruitment to the Corneal Stroma in a Murine Model of Onchocerca volvulus Keratitis

  2009cited by this paper
• O Antigen Allows B. parapertussis to Evade B. pertussis Vaccine–Induced Immunity by Blocking Binding and Functions of Cross-Reactive Antibodies

  2009cited by this paper
• The effects of IL-6 on CD4 T cell responses.

  2009cited by this paper
• Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

  2008cited by this paper
• Mast Cell IL-6 Improves Survival from Klebsiella Pneumonia and Sepsis by Enhancing Neutrophil Killing1

  2008cited by this paper
• Delayed Role of Tumor Necrosis Factor—α in Overcoming the Effects of Pertussis Toxin

  2007cited by this paper
• Interleukin-12 Promotes Gamma Interferon-Dependent Neutrophil Recruitment in the Lung and Improves Protection against Respiratory Streptococcus pneumoniae Infection

  2007cited by this paper
• The O Antigen Enables Bordetella parapertussis To Avoid Bordetella pertussis-Induced Immunity

  2007cited by this paper
• Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor.

  2007cited by this paper
• Use of a Genetically Defined Double Mutant Strain of Bordetella bronchiseptica Lacking Adenylate Cyclase and Type III Secretion as a Live Vaccine

  2007cited by this paper
• Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxin.

  2007cited by this paper
• Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics

  2006cited by this paper
• TLR4 Mediates Vaccine-Induced Protective Cellular Immunity to Bordetella pertussis: Role of IL-17-Producing T Cells1

  2006cited by this paper
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

  2006cited by this paper
• The Bordetella bronchiseptica Type III Secretion System Inhibits Gamma Interferon Production That Is Required for Efficient Antibody-Mediated Bacterial Clearance

  2006cited by this paper
• The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

  2006cited by this paper
• Interleukin-6 and rheumatic diseases

  2006cited by this paper
• Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies

  2005cited by this paper
• Bordetella pertussis-Infected Human Monocyte-Derived Dendritic Cells Undergo Maturation and Induce Th1 Polarization and Interleukin-23 Expression

  2005cited by this paper
• IL-23 Compensates for the Absence of IL-12p70 and Is Essential for the IL-17 Response during Tuberculosis but Is Dispensable for Protection and Antigen-Specific IFN-γ Responses if IL-12p70 Is Available1

  2005cited by this paper
• A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

  2005cited by this paper
• IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

  2005cited by this paper
• Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

  2005cited by this paper
• Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis.

  2005cited by this paper
• Clearance of Bordetella parapertussis from the Lower Respiratory Tract Requires Humoral and Cellular Immunity

  2005cited by this paper
• Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae

  2005cited by this paper
• Directing Transition from Innate to Acquired Immunity: Defining a Role for IL-61

  2005cited by this paper
• Comparative Toll-Like Receptor 4-Mediated Innate Host Defense to Bordetella Infection

  2005cited by this paper
• The interface between innate and adaptive immunity

  2004cited by this paper
• How best to estimate the global burden of pertussis?

  2003cited by this paper
• Role of Antibodies in Immunity to Bordetella Infections

  2003influential reference
• CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism 1

  2003cited by this paper
• The role of IL-17 and family members in the pathogenesis of arthritis.

  2003cited by this paper
• The changing age and seasonal profile of pertussis in Canada.

  2002cited by this paper
• Pertussis of adults and infants.

  2002cited by this paper
• Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage.

  2002cited by this paper
• Fc Receptor-Mediated Immunity Against Bordetella pertussis1

  2001cited by this paper
• Immunity to Bordetella pertussis.

  2001cited by this paper
• Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines.

  2001cited by this paper
• Protective Immunity to Bordetella pertussis Requires Both B Cells and Cd4+ T Cells for Key Functions Other than Specific Antibody Production

  2000cited by this paper
• Bordetella pertussis Virulence Factors Affect Phagocytosis by Human Neutrophils

  2000cited by this paper
• Phagocytosed Bordetella pertussis Fails To Survive in Human Neutrophils

  2000cited by this paper
• Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.

  2000cited by this paper
• Multiple Roles for Bordetella Lipopolysaccharide Molecules during Respiratory Tract Infection

  2000cited by this paper
• Induction of Proinflammatory Cytokines from Human Respiratory Epithelial Cells after Stimulation by NontypeableHaemophilus influenzae

  2000cited by this paper
• Multiple Roles for BordetellaLipopolysaccharide Molecules during Respiratory Tract Infection

  2000cited by this paper
• Fluorescent Labels Influence Phagocytosis ofBordetella pertussis by Human Neutrophils

  1999cited by this paper
• Interferon-gamma mediated immune effector mechanisms against Bordetella pertussis.

  1999cited by this paper
• Interferon-γ mediated immune effector mechanisms against Bordetella pertussis

  1999cited by this paper
• Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28.

  1998cited by this paper
• Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis.

  1998cited by this paper
• A Murine Model in Which Protection Correlates with Pertussis Vaccine Efficacy in Children Reveals Complementary Roles for Humoral and Cell-Mediated Immunity in Protection againstBordetella pertussis

  1998cited by this paper
• A Role for Interleukin-6 in Host Defense against Murine Chlamydia trachomatis Infection

  1998cited by this paper
• Copyright © 1997, American Society for Microbiology Lethal Tuberculosis in Interleukin-6-Deficient Mutant Mice

  1997cited by this paper
• Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

  1997cited by this paper
• Atypical Disease after Bordetella pertussis Respiratory Infection of Mice with Targeted Disruptions of Interferon-γ Receptor or Immunoglobulin μ Chain Genes

  1997cited by this paper
• Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia.

  1997cited by this paper
• Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells

  1996cited by this paper
• Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T‐cell subsets as Th1, Th2 or Th0

  1996cited by this paper
• Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection

  1996cited by this paper
• Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans

  1996cited by this paper
• Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia

  1995cited by this paper
• Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells.

  1995cited by this paper
• Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins

  1994cited by this paper
• Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model

  1993cited by this paper
• Interleukin-6 in biology and medicine.

  1993cited by this paper
• Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes

  1992cited by this paper
• Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis

  1991cited by this paper
• Interleukin-6: an overview.

  1990cited by this paper
• Synergistic interactions of IL-1 and IL-6 in T cell activation. Mitogen but not antigen receptor-induced proliferation of a cloned T helper cell line is enhanced by exogenous IL-6.

  1989cited by this paper
• IgG1 plasmacytosis in interleukin 6 transgenic mice.

  1989cited by this paper
• A simple chemically defined medium for the production of phase I Bordetella pertussis.

  1970cited by this paper

• The assessment of IL-6 in immune response to hepatitis B among hepatitis B vaccinated individuals in Specialist Hospital Sokoto State, North-Western Nigeria

  2025cites this paper
• Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice

  2024cites this paper
• Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge

  2023cites this paper
• Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age

  2021cites this paper
• Susceptibility of Human Airway Tissue Models Derived From Different Anatomical Sites to Bordetella pertussis and Its Virulence Factor Adenylate Cyclase Toxin

  2021cites this paper
• Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to <named-content content-type='genus-species'>Bordetella pertussis</named-content> in Mice

  2021cites this paper
• Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice

  2021cites this paper
• Reinvestigating the Coughing Rat Model of Pertussis To Understand Bordetella pertussis Pathogenesis

  2021cites this paper
• Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice

  2020cites this paper
• Development of Improved Acellular Pertussis Vaccines Through Inclusion of the RTX Antigen or Induction of Mucosal Immunity

  2019cites this paper
• Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis

  2019cites this paper
• Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice

  2018cites this paper
• Review of the neutrophil response to Bordetella pertussis infection.

  2015cites this paper
• Estudio de la estimulación de la respuesta innata en mucosas inducida por agonistas en la protección contra pertussis , una enfermedad considerada resurgente

  2015cites this paper
• Caspase-1-Independent Interleukin-1β Is Required for Clearance of Bordetella pertussis Infections and Whole-Cell Vaccine-Mediated Immunity

  2014cites this paper
• Human metapneumovirus inhibits the IL-6-induced JAK/STAT3 signalling cascade in airway epithelium.

  2014cites this paper
• The baboon model of pertussis: effective use and lessons for pertussis vaccines

  2014cites this paper
• Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

  2013cites this paper
• The Role of TssG, a Highly Conserved Component of the Type VI Secretion System, in Immune Modulation by Bordetella bronchiseptica

  2013cites this paper
• Integrated Immunotherapy for Breast Cancer

  2013cites this paper
• Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates

  2012cites this paper
• Immunity to the respiratory pathogen Bordetella pertussis

  2012cites this paper